PlainRecalls
FDA Drug Moderate Class II Terminated

Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07

Reported: July 13, 2022 Initiated: June 16, 2022 #D-1174-2022

Product Description

Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07

Reason for Recall

Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
168690 Tablets
Distribution
Distributed Nationwide and Puerto Rico.
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07. Recalled by Macleods Pharma Usa Inc. Units affected: 168690 Tablets.
Why was this product recalled?
Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 13, 2022. Severity: Moderate. Recall number: D-1174-2022.